Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

First cohort successfully completed in phase I study of HFB-30132A

Oct. 27, 2020

NOI initiates phase IIb/IIIa trial of first oral systemic NO-based therapeutic for COVID-19

Oct. 27, 2020

University of Central Florida patents new antimalarials

Oct. 26, 2020

Preclinical data presented for UB-612 vaccine against COVID-19

Oct. 26, 2020

Immutep announces investigator-initiated study of eftilagimod alpha in patients with COVID-19

Oct. 26, 2020

IAVI, Merck KGaA and Serum Institute of India collaborate to develop MAbs for COVID-19

Oct. 26, 2020

SARS-CoV-2 vaccine BBIBP-CorV safe and induces humoral responses in phase I/II study

Oct. 23, 2020

ProTrans approved for clinical trials in patients with COVID-19

Oct. 23, 2020

FDA approves Veklury for patients with COVID-19 requiring hospitalization

Oct. 23, 2020

GlaxoSmithKline patents hSTING agonists

Oct. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...